Cargando…

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial

BACKGROUND: Current influenza vaccines, based on antibodies against surface antigens, are unable to provide protection against newly emerging virus strains which differ from the vaccine strains. Therefore the population has to be re-vaccinated annually. It is thus important to develop vaccines which...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Doorn, Eva, Pleguezuelos, Olga, Liu, Heng, Fernandez, Ana, Bannister, Robin, Stoloff, Gregory, Oftung, Fredrik, Norley, Stephen, Huckriede, Anke, Frijlink, Henderik W., Hak, Eelko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379643/ https://www.ncbi.nlm.nih.gov/pubmed/28376743 http://dx.doi.org/10.1186/s12879-017-2341-9

Ejemplares similares

FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay
por: Oftung, Fredrik, et al.
Publicado: (2022)

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol
por: van Doorn, Eva, et al.
Publicado: (2017)

Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study
por: Pleguezuelos, Olga, et al.
Publicado: (2020)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro
por: Heida, Rick, et al.
Publicado: (2022)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures
por: Geeraedts, Felix, et al.
Publicado: (2010)

Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus
por: Bhide, Yoshita, et al.
Publicado: (2018)

Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge
por: Tomar, Jasmine, et al.
Publicado: (2018)

Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice
por: Heida, Rick, et al.
Publicado: (2023)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities
por: Amorij, J-P., et al.
Publicado: (2008)

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
por: Patil, Harshad P., et al.
Publicado: (2017)

A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice
por: van der Kooij, Renée S., et al.
Publicado: (2023)

Developments in the formulation and delivery of spray dried vaccines
por: Kanojia, Gaurav, et al.
Publicado: (2017)

Advances in the development of entry inhibitors for sialic-acid-targeting viruses
por: Heida, Rick, et al.
Publicado: (2021)

Development of an Orodispersible Film Containing Stabilized Influenza Vaccine
por: Tian, Yu, et al.
Publicado: (2020)

Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation
por: Pleguezuelos, Olga, et al.
Publicado: (2013)

Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge
por: Tomar, Jasmine, et al.
Publicado: (2018)

Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review
por: Nugrahadi, Primawan Putra, et al.
Publicado: (2023)

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine
por: Sibum, Imco, et al.
Publicado: (2019)

Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery
por: Broesder, Annemarie, et al.
Publicado: (2021)

National Differences in Requirements for Ethical and Competent Authority Approval for a Multinational Vaccine Trial under the EU Directive 2001/20/EC
por: van Doorn, Eva, et al.
Publicado: (2015)

Pharmacokinetics of a Prototype Formulation of Sublingual Testosterone and a Buspirone Tablet, Versus an Advanced Combination Tablet of Testosterone and Buspirone in Healthy Premenopausal Women
por: van Rooij, Kim, et al.
Publicado: (2014)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability
por: Bigaeva, Emilia, et al.
Publicado: (2016)

Immunogenic Yeast-Based Fermentate for Cold/Flu-like Symptoms in Nonvaccinated Individuals
por: Moyad, Mark A., et al.
Publicado: (2010)

Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations
por: Tapia-Calle, Gabriela, et al.
Publicado: (2017)

Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
por: Heida, Rick, et al.
Publicado: (2023)

A Novel M2e Based Flu Vaccine Formulation for Dogs
por: Leclerc, Denis, et al.
Publicado: (2013)

Formulation of a 3D Printed Biopharmaceutical: The Development of an Alkaline Phosphatase Containing Tablet with Ileo-Colonic Release Profile to Treat Ulcerative Colitis
por: Nguyen, Khanh T. T., et al.
Publicado: (2022)

Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs
por: de Waard, Hans, et al.
Publicado: (2010)

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu
por: Nechaeva, Elena A, et al.
Publicado: (2015)

1954. A Randomized Study to Evaluate the Shedding and Immunogenicity of H1N1 Strains in Trivalent and Quadrivalent Formulations of FluMist in Children 24 to <48 Months of Age
por: Mallory, Raburn, et al.
Publicado: (2018)

From SARS and avian flu to swine flu
por: Wong, G.W.K.
Publicado: (2010)

Phosphate reabsorption in the kidney: NaPi-IIb or not IIb
por: Burns, David, et al.
Publicado: (2020)

Immunoglobulin Infusion as Therapy Against Influenza?
por: Huckriede, Anke
Publicado: (2017)

Drug Content Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation
por: Grasmeijer, Floris, et al.
Publicado: (2013)

Correction: Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation
por: Grasmeijer, Floris, et al.
Publicado: (2013)

Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation
por: Grasmeijer, Floris, et al.
Publicado: (2013)

Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial
por: Friedman-Klabanoff, DeAnna J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1kmbfs60slf4ivaej0k3u1cv7a